GDPR’s involvement in Clinical Trials

What is the new GDPR and how will it affect the Clinical Research Sector? The new General Data Protection Regulation (No. 2016/679, or ‘GDPR’) came into force on 25 May 2018 across all EU countries including the UK. The new Regulation aims to provide a high level of protection for personal data, to ensure that

Continue Reading

Recent study data by the FDA has found that older blood cancer patients (75+) are severely under-represented in clinical trials

Results from the FDA’s first comprehensive examination of clinical trial enrolment in older patients with blood cancers has revealed that patients over 75 are significantly underrepresented. When looking at the occurrence of these conditions, it has recently been found that one in five patients in the US who are diagnosed with blood cancer are over

Continue Reading

New bladder cancer treatment to be trialled in UK

An experimental therapy for bladder cancer is predicted to soon be entering Phase I clinical trials in the UK following a development pact signed between Cancer Research UK, its commercial arm Cancer Research Technology, and Sitka Biopharma, a Canadian biotech. Sitka’s therapy (STK-01) is being developed to improve delivery of chemotherapy in non-muscle invasive bladder

Continue Reading